Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Landuzzi

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Cancers|December 1, 2019
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental ModelCarla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, et al.
Cells|February 9, 2024
IL-1 Family Members in Bone SarcomasLorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, et al.
Current Drug Targets|December 17, 2010
Vaccines and other immunological approaches for cancer immunopreventionPier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.
Oncology Reports|July 6, 2007
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cellsStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivoStewart Sale, Isabel L Fong, Carla de Giovanni, et al.
Pathology Oncology Research : POR|December 26, 2007
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesisStefania Croci, Lorena Landuzzi, Giordano Nicoletti, et al.
International Journal of Cancer|January 30, 2004
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosityCarla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Differentiation; Research in Biological Diversity|December 7, 2010
TRAF6 regulates proliferation and differentiation of skeletal myoblastsTobias Mueck, Felicitas Berger, Ingrid Buechsler, et al.
Cancers|January 20, 2021
IFN-γ and CD38 in Hyperprogressive Cancer DevelopmentStefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, et al.
BMC Cancer|February 9, 2019
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasisCarla De Giovanni, Patrizia Nanni, Lorena Landuzzi, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Cancers|December 1, 2019
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental ModelCarla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, et al.
Cells|February 9, 2024
IL-1 Family Members in Bone SarcomasLorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, et al.
Current Drug Targets|December 17, 2010
Vaccines and other immunological approaches for cancer immunopreventionPier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.
Oncology Reports|July 6, 2007
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cellsStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivoStewart Sale, Isabel L Fong, Carla de Giovanni, et al.
Pathology Oncology Research : POR|December 26, 2007
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesisStefania Croci, Lorena Landuzzi, Giordano Nicoletti, et al.
International Journal of Cancer|January 30, 2004
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosityCarla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Differentiation; Research in Biological Diversity|December 7, 2010
TRAF6 regulates proliferation and differentiation of skeletal myoblastsTobias Mueck, Felicitas Berger, Ingrid Buechsler, et al.
Cancers|January 20, 2021
IFN-γ and CD38 in Hyperprogressive Cancer DevelopmentStefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, et al.
BMC Cancer|February 9, 2019
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasisCarla De Giovanni, Patrizia Nanni, Lorena Landuzzi, et al.
Pageof 9